128 related articles for article (PubMed ID: 37638394)
1. Prevalence of erythromycin-resistant emm92-type invasive group A streptococcal infections among injection drug users in West Virginia, United States, 2021-23.
Powell LM; Choi SJ; Haught BL; Demkowicz R; LaSala PR; Lukomski S
J Antimicrob Chemother; 2023 Oct; 78(10):2554-2558. PubMed ID: 37638394
[TBL] [Abstract][Full Text] [Related]
2. Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020-2021.
Powell LM; Choi SJ; Chipman CE; Grund ME; LaSala PR; Lukomski S
Emerg Infect Dis; 2023 May; 29(5):898-908. PubMed ID: 37080963
[TBL] [Abstract][Full Text] [Related]
3. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results.
Desjardins M; Delgaty KL; Ramotar K; Seetaram C; Toye B
J Clin Microbiol; 2004 Dec; 42(12):5620-3. PubMed ID: 15583291
[TBL] [Abstract][Full Text] [Related]
5. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
[TBL] [Abstract][Full Text] [Related]
6. [Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period].
Rodríguez C; Rojas P; Wozniak A; Kalergis AM; Cerón I; Riedel I; Román JC; Villarroel LA; Berríos X; Bavestrello L; García P
Rev Med Chil; 2011 Sep; 139(9):1143-9. PubMed ID: 22215392
[TBL] [Abstract][Full Text] [Related]
7. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
[TBL] [Abstract][Full Text] [Related]
8. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California.
York MK; Gibbs L; Perdreau-Remington F; Brooks GF
J Clin Microbiol; 1999 Jun; 37(6):1727-31. PubMed ID: 10325315
[TBL] [Abstract][Full Text] [Related]
9. Unexpected relationships between frequency of antimicrobial resistance, disease phenotype and
Sanson MA; Macias OR; Shah BJ; Hanson B; Vega LA; Alamarat Z; Flores AR
Microb Genom; 2019 Nov; 5(11):. PubMed ID: 31755853
[TBL] [Abstract][Full Text] [Related]
10. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
[TBL] [Abstract][Full Text] [Related]
11. Clindamycin resistant emm33 Streptococcus pyogenes emerged among invasive infections in Helsinki metropolitan area, Finland, 2012 to 2013.
Pesola AK; Sihvonen R; Lindholm L; Pätäri-Sampo A
Euro Surveill; 2015 May; 20(18):. PubMed ID: 25990232
[TBL] [Abstract][Full Text] [Related]
12. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens.
Melo-Cristino J; Fernandes ML
Microb Drug Resist; 1999; 5(3):219-25. PubMed ID: 10566873
[TBL] [Abstract][Full Text] [Related]
13. [Problems with identification of beta-hemolytic streptococcus resistant to bacitracin isolated from patients with pharyngitis].
Olender A; Łetowska I; Karyński M; Kiernicka-Ciekot K; Pels K
Med Dosw Mikrobiol; 2012; 64(1):1-10. PubMed ID: 22808724
[TBL] [Abstract][Full Text] [Related]
14. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Antibiotic Nonsusceptibility Among Invasive Group A Streptococcus Infections-United States, 2006-2017.
Fay K; Onukwube J; Chochua S; Schaffner W; Cieslak P; Lynfield R; Muse A; Smelser C; Harrison LH; Farley M; Petit S; Alden N; Apostal M; Snippes Vagnone P; Nanduri S; Beall B; Van Beneden CA
Clin Infect Dis; 2021 Dec; 73(11):1957-1964. PubMed ID: 34170310
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children.
Syrogiannopoulos GA; Grivea IN; Fitoussi F; Doit C; Katopodis GD; Bingen E; Beratis NG
Pediatr Infect Dis J; 2001 Sep; 20(9):863-8. PubMed ID: 11734765
[TBL] [Abstract][Full Text] [Related]
17. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010.
Villaseñor-Sierra A; Katahira E; Jaramillo-Valdivia AN; Barajas-García Mde L; Bryant A; Morfín-Otero R; Márquez-Díaz F; Tinoco JC; Sánchez-Corona J; Stevens DL
Int J Infect Dis; 2012 Mar; 16(3):e178-81. PubMed ID: 22217469
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
Alós JI; Aracil B; Oteo J; Torres C; Gómez-Garcés JL
J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081
[TBL] [Abstract][Full Text] [Related]
19. Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.
Chen I; Kaufisi P; Erdem G
J Clin Microbiol; 2011 Jan; 49(1):439-41. PubMed ID: 21068284
[TBL] [Abstract][Full Text] [Related]
20. Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007-2019.
Villalón P; Sáez-Nieto JA; Rubio-López V; Medina-Pascual MJ; Garrido N; Carrasco G; Pino-Rosa S; Valdezate S
Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2295-2303. PubMed ID: 34046804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
